SCHEMBL20569200

SCHEMBL20569200

CCOC(=O)CCC1=CC=CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.47
CYP4A11 Q02928 3/20 0.47
ALDH1A1 P00352 4/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 1/20 0.41
GAA P10253 2/20 0.40
CYP1A2 P05177 1/20 0.39
CYP4Z1 Q86W10 1/20 0.38
MGAM O43451 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
HPGD P15428 1/20 0.37
USP2 O75604 1/20 0.37
ALOX15 P16050 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PTPN1 P18031 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28992199 0.80 DGKA (0.41) ALDH1A1KDM4EHSD17B10TDP1
SCHEMBL28992200 0.76 NAAA (0.43) ALDH1A1KDM4EGAACYP1A2HPGD
SCHEMBL20570206 0.76 NPC1 (0.39) ALDH1A1LMNAMAPTTDP1L3MBTL1
SCHEMBL12828405 0.75 CYP4F2 (0.39) CYP4F2CYP4A11ALDH1A1LMNAMAPT
SCHEMBL28992213 0.73 NAAA (0.49) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL28992178 0.73 NAAA (0.49) ALDH1A1LMNAKDM4EGAACYP1A2
SCHEMBL6515283 0.73 CYP1A2 (0.41) CYP4F2CYP4A11ALDH1A1LMNAKDM4E
SCHEMBL20571647 0.73 PSMB8 (0.39)
SCHEMBL22184133 0.73 NPC1 (0.43) ALDH1A1LMNAKDM4EMAPTTDP1
SCHEMBL13838043 0.72 TSHR (0.47) ALDH1A1LMNAHSD17B10MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250152728-A1 Method And Molecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-05-15 US disclosed
US-20230321267-A1 Method And Molecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-10-12 US disclosed
US-11759526-B2 Method and molecules MEDIMMUNE, LLC (US) 2023-09-19 US disclosed
EP-4223319-A2 METHOD AND MOLECULES MedImmune, LLC (US) 2023-08-09 EP disclosed
EP-3630732-B1 METHOD AND MOLECULES MEDIMMUNE LLC (US) 2023-07-12 EP disclosed
US-20200206359-A1 Method And Molecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-07-02 US disclosed
EP-3630732-A1 METHOD AND MOLECULES Medimmune, LLC (US) 2020-04-08 EP disclosed
WO-2018218093-A1 METHOD AND MOLECULES MEDIMMUNE, LLC (US) 2018-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250152728-A1 Method And Molecules PAICS, EPCAM, SQLE CYP4F2 259/4885CYP4A11 856/4885ALDH1A1 27/4885
US-20200206359-A1 Method And Molecules PAICS, EPCAM, SQLE CYP4F2 259/4885CYP4A11 856/4885ALDH1A1 27/4885
US-20230321267-A1 Method And Molecules PAICS, EPCAM, SQLE CYP4F2 259/4885CYP4A11 856/4885ALDH1A1 27/4885
US-11759526-B2 Method and molecules PAICS, EPCAM, SQLE CYP4F2 259/4885CYP4A11 856/4885ALDH1A1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.